Takeda Pharmaceutical TAK will release its quarterly earnings report on Thursday, 2024-10-31. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Takeda Pharmaceutical to report an earnings per share (EPS) of $0.58.
The market awaits Takeda Pharmaceutical's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Here's a look at Takeda Pharmaceutical's past performance and the resulting price change:
| Quarter | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| EPS Estimate | ||||
| EPS Actual | 0.56 | 0.24 | 0.51 | 0.48 |
| Price Change % | -0.0% | -1.0% | -1.0% | 1.0% |
To track all earnings releases for Takeda Pharmaceutical visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
